Stromal cells expressing elevated VCAM-1 enhance survival of B lineage tumor cells

Cancer Letters

Volumn 207, Issue 2, 2004, Pages 229-239

  Hall, Brett M ^a   Fortney, James E ^b   Taylor, Lela ^a   Wood, Hillary ^a   Wang, Lin ^b   Adams, Scott ^b   Davis, Suzanne ^a   Gibson, Laura F ^a,b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Leukemia; Stromal cells

Indexed keywords

PHOSPHOTRANSFERASE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; GENETIC ENGINEERING; LEUKEMIA CELL; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; TUMOR CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTINEOPLASTIC AGENTS; BONE MARROW CELLS; CELL SURVIVAL; COCULTURE TECHNIQUES; ETOPOSIDE; HUMANS; LEUKEMIA, B-CELL; MICE; PROTO-ONCOGENE PROTEINS C-BCL-2; STROMAL CELLS; TUMOR CELLS, CULTURED; VASCULAR CELL ADHESION MOLECULE-1;

MURINAE;

EID: 1842606395     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.10.033     Document Type: Article

References (41)

1. LeClerc J.M., Billett A.L., Gelber R.D., Dalton V., Tarbell N., Lipton J.M., et al. Treatment of childhood acute lymphoblastic leukemia: results of Dana- Farber ALL Consortium Protocol 87-01. J. Clin. Oncol. 20:2002;237-246.
2. Bradstock K.F., Gottlieb D.J. Interaction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual disease. Leuk. Lymphoma. 18:1995;1-16.
3. Wasserman R., Galili N., Ito Y., Silber J.H., Reichard B.A., Shane S., Womer R.B., Lange B., Rovera G. Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia. J. Clin. Oncol. 10:1992;1879-1888.
4. Campana D., Coustan-Smith E. Detection of minimal residual disease in acute leukemia by flow cytometry. Cytometry. 38:1999;139-152.
5. Biondi A., Valsecchi M.G., Seriu T., D'Aniello E., Willemse M.J., Fasching K., et al. Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group. Leukemia. 14:2000;1939-1943.
6. Kamel-Reid S., Letarte M., Doedens M., Greaves A., Murdoch B., Grunberger T., et al. Bone marrow from children in relapse with pre-B acute lymphoblastic leukemia proliferates and disseminates rapidly in scid mice. Blood. 78:1991;2973-2981.
7. Brisco M.J., Condon J., Hughes E., Neoh S.H., Sykes P.J., Seshadri R., et al. Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction (see comments). Lancet. 343:1994;196-200.
8. Kumagai M., Manabe A., Coustan-Smith E., Blakley R.L., Beck W.T., Santana V.M., et al. Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. II. Potent cytotoxicity of 2-chloro-deoxyadenosine in acute lymphoblastic leukemia. Leukemia. 8:1994;1116-1123.
9. Murti K.G., Brown P.S., Kumagai M., Campana D. Molecular interactions between human B-cell progenitors and the bone marrow microenvironment. Exp.Cell Res. 226:1996;47-58.
10. Mirro J. Jr., Hurwitz C.A., Behm F.G., Head D.R., Raimondi S.C., Crist W.M., Ihle J.N. Effects of recombinant human hematopoietic growth factors on leukemic blasts from children with acute myeloblastic or lymphoblastic leukemia. Leukemia. 7:1993;1026-1033.
11. Manabe A., Coustan-Smith E., Behm F.G., Raimondi S.C., Campana D. Bone marrow-derived stromal cells prevent apoptotic cell death in B- lineage acute lymphoblastic leukemia. Blood. 79:1992;2370-2377.
12. Campana D., Manabe A., Evans W.E. Stroma-supported immunocytometric assay (SIA): a novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs. Leukemia. 7:1993;482-488.
13. Kumagai M., Coustan-Smith E., Murray D.J., Silvennoinen O., Murti K.G., Evans W.E., et al. Ligation of CD38 suppresses human B lymphopoiesis. J. Exp. Med. 181:1995;1101-1110.
14. Kumagai M., Manabe A., Pui C.H., Behm F.G., Raimondi S.C., Hancock M.L., et al. Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome. J. Clin. Invest. 97:1996;755-760.
15. Ashley D.M., Bol S.J., Kannourakis G. Viable bone marrow stromal cells are required for the in vitro survival of B-cell precursor acute lymphoblastic leukemic cells. Leuk. Res. 19:1995;113-120.
16. Lagneaux L., Delforge A., Bron D., De Bruyn C., Stryckmans P. Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood. 91:1998;2387-2396.
17. Panayiotidis P., Jones D., Ganeshaguru K., Foroni L., Hoffbrand A.V. Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br. J. Haematol. 92:1996;97-103.
18. Miyake K., Medina K., Ishihara K., Kimoto M., Auerbach R., Kincade P.W. A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture. J. Cell Biol. 114:1991;557-565.
19. Dittel B.N., LeBien T.W. Reduced expression of vascular cell adhesion molecule-1 on bone marrow stromal cells isolated from marrow transplant recipients correlates with a reduced capacity to support human B lymphopoiesis in vitro. Blood. 86:1995;2833-2841.
20. Sarkar S., Svoboda M., de Beaumont R., Freedman A.S. The role of Akt and RAFTK in beta1 integrin mediated survival of precursor B-acute lymphoblastic leukemia cells. Leuk. Lymphoma. 43:2002;1663-1671.
21. Makrynikola V., Kabral A., Bradstock K.F. Effects of recombinant human cytokines on precursor-B acute lymphoblastic leukemia cells. Exp. Hematol. 19:1991;674-679.
22. Manabe A., Murti K.G., Coustan-Smith E., Kumagai M., Behm F.G., Raimondi S.C., Campana D. Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. Blood. 83:1994;758-766.
23. Reyes-Reyes M., Mora N., Gonzalez G., Rosales C. beta1 and beta2 integrins activate different signalling pathways in monocytes. Biochem. J. 363:2002;273-280.
24. Tian B., Lessan K., Kahm J., Kleidon J., Henke C. beta 1 integrin regulates fibroblast viability during collagen matrix contraction through a phosphatidylinositol 3-kinase/Akt/protein kinase B signaling pathway. J. Biol. Chem. 277:2002;24667-24675.
25. Gibson L.F., Fortney J., Landreth K.S., Piktel D., Ericson S.G., Lynch J.P. Disruption of bone marrow stromal cell function by etoposide. Biol. Blood Marrow Transplant. 3:1997;22-132.
26. Mudry R.E., Fortney J.E., York T., Hall B.M., Gibson L.F. Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy. Blood. 96:2000;1926-1932.
27. Fortney J.E., Zhao W., Wenger S.L., Gibson L.F. Bone marrow stromal cells regulate caspase 3 activity in leukemic cells during chemotherapy. Leuk. Res. 25:2001;901-907.
28. Fortney J.E., Hall B.M., Bartrug L., Gibson L.F. Chemotherapy induces bcl-2 cleavage in lymphoid leukemic cell lines. Leuk. Lymphoma. 43:2002;2171-2178.
29. Collins L.S., Dorshkind K. A stromal cell line from myeloid long-term bone marrow cultures can support myelopoiesis and B lymphopoiesis. J. Immunol. 138:1987;1082-1087.
30. Bowen J.A., Hunt J.S. Expression of cell adhesion molecules in murine placentas and a placental cell line. Biol. Reprod. 60:1999;428-434.
31. Pietersma A., Tilly B.C., Gaestel M., de Jong N., Lee J.C., Koster J.F., Sluiter W. p38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level. Biochem. Biophys. Res. Commun. 230:1997;44-48.
32. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
33. Kamel-Reid S., Letarte M., Doedens M., Greaves A., Murdoch B., Grunberger T., et al. Bone marrow from children in relapse with pre-B acute lymphoblastic leukemia proliferates and disseminates rapidly in scid mice. Blood. 78:1991;2973-2981.
34. Brendel C., Neubauer A. Characteristics and analysis of normal and leukemic stem cells: current concepts and future directions. Leukemia. 14:2000;1711-1717.
35. Ren R. The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine model. Oncogene. 21:2002;8629-8642.
36. Cobaleda C., Gutierrez-Cianca N., Perez-Losada J., Flores T., Garcia-Sanz R., Gonzalez M., Sanchez-Garcia I. A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia. Blood. 95:2000;1007-1013.
37. Quijano C.A., Moore D., Arthur D., Feusner J., Winter S.S., Pallavicini M.G. Cytogenetically aberrant cells are present in the CD34+CD33-38-19- marrow compartment in children with acute lymphoblastic leukemia. Leukemia. 1997;111508-111515.
38. Look A.T. Oncogenic transcription factors in the human acute leukemias. Science. 278:1997;1059-1064.
39. Crans H.N., Sakamoto K.M. Transcription factors and translocations in lymphoid and myeloid leukemia. Leukemia. 15:2001;313-331.
40. Cheng E.H., Kirsch D.G., Clem R.J., Ravi R., Kastan M.B., Bedi A., Ueno K., Hardwick J.M. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science. 278:1997;1966-1968.
41. Fadeel B., Hassan Z., Hellstrom-Lindberg E., Henter J.I., Orrenius S., Zhivotovsky B. Cleavage of Bcl-2 is an early event in chemotherapy-induced apoptosis of human myeloid leukemia cells. Leukemia. 13:1999;719-728.